Our Pricing

Mounjaro Discount Code UK Pharmacy

Published on: June 03, 2026

Searching for a genuine mounjaro discount code uk pharmacy offer? Cured Pharmacy provides transparent upfront pricing on UK-licensed Mounjaro (tirzepatide) from £124.99, with free clinical consultations completed in under three minutes by our UK-registered prescribers. Every treatment includes discreet next-day delivery and our lowest price guarantee across the UK.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the landmark SURPASS-3 clinical trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks—substantially higher than comparator treatments [1]. The dual-agonist mechanism appears to delay gastric emptying more effectively whilst reducing food intake through central appetite pathways in the hypothalamus [2].

Mounjaro is administered as a once-weekly subcutaneous injection using the convenient KwikPen device. Dosing begins at 2.5mg weekly for four weeks, then escalates gradually to minimise gastrointestinal side effects whilst optimising therapeutic response. Your UK prescriber will determine the appropriate maintenance dose based on your individual tolerance and weight loss progress during follow-up consultations.

Mounjaro Discount Code UK Pharmacy Pricing

At Cured Pharmacy, Mounjaro starts from £124.99 per treatment cycle, representing competitive UK pricing with full transparency before your consultation begins. Unlike some online services that reveal costs only after assessment, we display exact pricing upfront so you can make informed decisions about your weight management journey.

Our pricing includes your UK-licensed medication dispensed by our GPhC-registered pharmacy (9012511), clinical assessment by a qualified prescriber, and discreet delivery to your door. There are no hidden consultation fees, and our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees every prescription to ensure safety and authenticity.

The final cost depends on your prescribed dose strength and treatment duration. Mounjaro is available in five dose strengths (2.5mg, 5mg, 7.5mg, 10mg, and 15mg), with most patients progressing through a dose-escalation schedule over several months. Your prescriber will discuss the most appropriate dosing pathway during your free three-minute online consultation.

Why Choose Cured Pharmacy for Mounjaro

We guarantee the lowest Mounjaro prices in the UK whilst maintaining the highest clinical standards. Every medication is sourced directly from UK-licensed wholesalers and stored in our temperature-controlled pharmacy facility. Our clinical team has supported thousands of UK patients through their weight loss journeys, providing ongoing prescriber reviews and lifestyle guidance throughout treatment.

You'll receive 100% discreet packaging with no pharmacy branding, delivered via tracked courier within 24 hours of prescription approval. Our customer care team is available on (+44) 116 4646009 during business hours to answer questions about your treatment, and our online consultation system allows convenient follow-up assessments without GP appointments.

Mounjaro vs Wegovy: Clinical Comparison

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are MHRA-licensed injectable treatments for chronic weight management, but they differ significantly in mechanism and clinical outcomes. Wegovy activates only GLP-1 receptors, whilst Mounjaro's dual GIP/GLP-1 action produces greater average weight loss in head-to-head comparisons [3].

The SURMOUNT-1 trial demonstrated that tirzepatide 15mg resulted in 22.5% average body weight reduction compared to 14.9% with semaglutide 2.4mg over similar timeframes [3]. Both medications require once-weekly subcutaneous injection and follow dose-escalation protocols to improve gastrointestinal tolerability. Common side effects include nausea, diarrhoea, and constipation, typically most pronounced during the first 4-8 weeks of treatment [1][4].

Your choice between these treatments depends on multiple factors including your medical history, previous medication responses, and cost considerations. Some patients experience better tolerability with one agent over the other. During your consultation, our UK prescriber will review your complete health profile to recommend the most appropriate option for your circumstances.

Alternative Weight Loss Treatments Available

Beyond injectable GLP-1 medications, Cured Pharmacy offers a comprehensive range of UK-licensed weight loss treatments. Saxenda (liraglutide) provides a daily injection option for patients who prefer more frequent dosing with shorter-acting medication. For those seeking oral alternatives, Wegovy oral tablets deliver semaglutide without injections, whilst Orlistat-based treatments (including branded Xenical and Alli) work through fat absorption inhibition rather than appetite suppression.

Each treatment class has distinct mechanisms, efficacy profiles, and side effect patterns. Orlistat typically produces 5-10% body weight reduction when combined with a reduced-calorie diet, whilst GLP-1 receptor agonists demonstrate 15-22% average reductions in clinical trials [1][5]. Your prescriber will discuss which approach aligns best with your weight loss goals, lifestyle preferences, and medical suitability during your assessment.

Who Can Use Mounjaro in the UK

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [6]. NICE guidance supports the use of pharmacological interventions like tirzepatide as part of a comprehensive weight management programme including dietary modification and increased physical activity.

The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or hypersensitivity to tirzepatide or any excipients. Caution is advised in patients with severe gastrointestinal disease, history of pancreatitis, or diabetic retinopathy. Women who are pregnant, planning pregnancy, or breastfeeding should not use Mounjaro [6].

During your online consultation at Cured Pharmacy, our UK prescriber will review your complete medical history, current medications, and any contraindications before determining whether Mounjaro is clinically appropriate. This assessment typically takes under three minutes to complete and ensures your safety throughout treatment. All prescription decisions remain at the clinical discretion of our qualified healthcare professionals.

How to Start Mounjaro Treatment

Beginning your Mounjaro journey at Cured Pharmacy requires just three simple steps. First, complete our free online consultation questionnaire, which asks about your weight history, current health conditions, medications, and weight loss goals. This secure assessment takes most patients under three minutes and can be completed on any device at your convenience.

Next, a UK-registered prescriber reviews your consultation within hours. If Mounjaro is deemed clinically appropriate for your circumstances, they'll issue an electronic prescription directly to our GPhC-registered pharmacy. You'll receive email confirmation once your prescription has been approved, along with tracking information for your delivery.

Finally, our pharmacy team dispenses your medication in discreet, unmarked packaging and arranges next-day delivery via tracked courier. Your first supply typically includes the starting 2.5mg dose along with detailed administration instructions and our direct contact information for any questions. Follow-up consultations can be completed online when you're ready to progress to higher maintenance doses.

Ongoing Support Throughout Your Journey

Weight loss with Mounjaro is most effective when combined with sustainable lifestyle changes. Our clinical team provides guidance on nutrition, physical activity, and behavioural strategies to maximise your results and maintain long-term success. You'll have access to follow-up prescriber consultations as you progress through dose escalations, allowing continuous monitoring of your response and any side effects.

Most patients remain on Mounjaro for 12-18 months to achieve their target weight loss, though treatment duration varies individually. Regular prescriber reviews ensure your treatment remains appropriate and effective throughout this period. Our pharmacy team is available via phone on (+44) 116 4646009 during business hours to address any medication queries or delivery concerns.

Mounjaro Safety and Side Effects

The most common side effects of Mounjaro affect the gastrointestinal system, particularly during initial dose escalation. In clinical trials, 20-30% of participants experienced nausea, whilst 15-20% reported diarrhoea or constipation [1]. These effects typically diminish over 4-8 weeks as your body adjusts to the medication. Starting at the low 2.5mg dose and gradually increasing helps minimise these symptoms.

Serious adverse events are uncommon but include pancreatitis (inflammation of the pancreas), gallbladder disease, acute kidney injury secondary to dehydration, and hypoglycaemia when used alongside other glucose-lowering medications. Patients should seek immediate medical attention if they experience severe abdominal pain, persistent vomiting, signs of dehydration, or allergic reactions [6].

Long-term safety data from the SURMOUNT trial programme demonstrates that tirzepatide maintains a favourable benefit-risk profile over extended treatment periods [7]. However, as with any prescription medication, ongoing monitoring by qualified healthcare professionals remains essential. Our UK prescribers conduct regular follow-up assessments to identify any emerging concerns and adjust your treatment plan accordingly.

If you experience concerning side effects whilst taking Mounjaro, contact our pharmacy team immediately or consult your GP. Never discontinue prescription medication without professional guidance. The MHRA's Yellow Card scheme allows patients to report suspected side effects directly, contributing to ongoing medication safety surveillance across the UK.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
6. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). https://www.medicines.org.uk/emc/product/14042/smpc [accessed 13 August 2026]
7. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro is a prescription-only medication and may not be suitable for everyone. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary—weight loss outcomes cited reflect clinical trial averages and cannot be guaranteed.